We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Sex differences in adipose insulin resistance are linked to obesity, lipolysis and insulin receptor substrate 1

    Background/Objective

    Insulin resistance is more prominent in men than women. If this involves adipose tissue is unknown and was presently examined.

    ...
    Peter Arner, Nathalie Viguerie, ... Daniel Peter Andersson in International Journal of Obesity
    Article Open access 15 March 2024
  2. LRP6 Bidirectionally Regulates Insulin Sensitivity through Insulin Receptor and S6K Signaling in Rats with CG-IUGR

    Objective

    Intrauterine growth restriction followed by postnatal catch-up growth (CG-IUGR) increases the risk of insulin resistance-related diseases....

    Xue-mei ** Xuan in Current Medical Science
    Article 13 March 2023
  3. Case report: Glycaemic management and pregnancy outcomes in a woman with an insulin receptor mutation, p.Met1180Lys

    Background

    Heterozygous insulin receptor mutations (INSR) are associated with insulin resistance, hyperglycaemia and hyperinsulinaemic hypoglycaemia...

    Mairéad T. Crowley, Eirena Goulden, ... Maria M. Byrne in Clinical Diabetes and Endocrinology
    Article Open access 10 March 2024
  4. Regimen comprising GLP-1 receptor agonist and basal insulin can decrease the effect of food on glycemic variability compared to a pre-mixed insulin regimen

    Background

    Increasing evidence suggests that glucagon-like peptide 1 (GLP-1) receptor agonists (RA) can stabilize glycemic variability (GV) and...

    Yi-Hsuan Lin, Chia-Hung Lin, ... Sheng-Hsuan Lin in European Journal of Medical Research
    Article Open access 03 December 2022
  5. The regulation of insulin receptor/insulin-like growth factor 1 receptor ratio, an important factor for breast cancer prognosis, by TRIP-Br1

    Much higher risk of cancer has been found in diabetes patients. Insulin receptor (IR) and insulin-like growth factor 1 receptor (IGF1R) have been...

    Thi Ngoc Quynh Nguyen, Samil Jung, ... Myeong-Sok Lee in Journal of Hematology & Oncology
    Article Open access 16 June 2022
  6. Insulin and the insulin receptor collaborate to promote human gastric cancer

    Background

    Gastric adenocarcinoma is common and consequent mortality high. Presentation and mortality are increased in obese individuals, many of whom...

    Marina Saisana, S. Michael Griffin, Felicity E. B. May in Gastric Cancer
    Article Open access 23 September 2021
  7. Association between insulin receptor substrate 1 gene polymorphism rs1801278 and gestational diabetes mellitus: an updated meta- analysis

    Objectives

    we performed this meta- analysis to investigate the impact of insulin receptor substrate 1 (IRS1) gene rs1801278 on susceptibility to...

    Lili Shen, Junli Liu, ... **aomei Hu in Diabetology & Metabolic Syndrome
    Article Open access 06 March 2024
  8. The effect of BsmI (rs1544410) single nucleotide polymorphism of vitamin D receptor (VDR) on insulin resistance in healthy children and adolescents: a cross-sectional study

    The increasing prevalence of metabolic syndrome, type 2 diabetes, and insulin resistance are driven by complex interactions between genetic and...

    Ahmad Gholami, Nima Montazeri-Najafabady, ... Elnaz Talei in BMC Pediatrics
    Article Open access 17 January 2024
  9. Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes

    Aims

    To evaluate and compare the effectiveness of once-daily insulin degludec/liraglutide (IDegLira) to that of once-daily insulin degludec/insulin...

    Junko Oya, Tomoko Nakagami, ... Tetsuya Babazono in Diabetology International
    Article 08 January 2024
  10. Distinct hypoglycemic effect of different formulations of a fixed ratio of basal insulin plus glucagon-like peptide-1 receptor agonist in a patient with pancreatic diabetes

    Fixed-ratio combination injection therapy (FRC) is a fixed-ratio mixture containing basal insulin and glucagon-like peptide-1 receptor agonist (GLP-1...

    Tomoko Yamada, Shun-ichiro Asahara, ... Kazuhiko Sakaguchi in Diabetology International
    Article 10 April 2023
  11. Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease

    Background

    Insulin resistance (IR) is a pathophysiologic hallmark of type 2 diabetes and associated with the presence of chronic kidney disease (CKD)....

    J. David Smeijer, Donald E. Kohan, ... Hiddo J. Lambers Heerspink in Cardiovascular Diabetology
    Article Open access 16 September 2023
  12. Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence

    Background

    In clinical trials enrolling patients with type 2 diabetes (T2D) at high cardiovascular risk, many glucagon-like peptide-1 receptor...

    Meir Schechter, Cheli Melzer Cohen, ... Ofri Mosenzon in Cardiovascular Diabetology
    Article Open access 27 May 2023
  13. Effect of insulin on IR and GLP1-R expressions in HT22 cells

    Insulin is a significant growth factor that specifically binds to the insulin receptor (IR) in the brain and then activates the PI3K-AKT pathway....

    Melek Tunc-Ata, Zeynep Mine Altunay, ... Vural Kucukatay in Medical Oncology
    Article 15 September 2023
  14. Effect of glucagon-like peptide-1 receptor agonist on insulin secretion index and serum Wnt5a protein in patients with new-onset type 2 diabetes mellitus

    Objective

    Previous studies have found that wnt5a promotes β-cell insulin secretion and reduced concentrations in patients with type 2 diabetes....

    Wei Xu, Y. Q. Sang, ... Jun Liang in Journal of Diabetes & Metabolic Disorders
    Article Open access 03 January 2023
  15. Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcoma

    Rhabdomyosarcoma (RMS) is an aggressive pediatric tumor with a poor prognosis for metastasis and recurrent disease. Large-scale sequencing endeavors...

    Safiya Khurshid, Matias Montes, ... Dawn Chandler in npj Precision Oncology
    Article Open access 11 January 2022
  16. Direct comparison two fixed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes

    Background

    Two types of fixed-ratio combinations of basal insulin and a glucagon-like peptide-1 receptor agonist (GLP-1RA) have been approved for use...

    Ivona Risovic, Mirjana Sumarac Dumanovic, ... Danijel Djekic in BMC Endocrine Disorders
    Article Open access 01 February 2023
  17. Thyroid cancer and insulin resistance

    Thyroid cancer has shown a parallel increase with diabetes in the last few years. This narrative review aims to explain the association between these...

    Gabriela Brenta, Fernando Di Fermo in Reviews in Endocrine and Metabolic Disorders
    Article 14 November 2023
  18. Insulin-like growth factor 1 receptor inhibits the proliferation of acute myeloid leukaemia cells via NK cell activation

    Acute myeloid leukaemia (AML) denotes a heterogeneous category of cancers occurring within the bone marrow that are initiated by the unrestricted...

    ShuQing Wang, Xuan Wang, ... Jian Li in Annals of Hematology
    Article 31 July 2023
Did you find what you were looking for? Share feedback.